Colgate-Palmolive (NYSE:CL) Stock Position Increased by Annex Advisory Services LLC

Annex Advisory Services LLC grew its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 1,844.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 76,905 shares of the company's stock after acquiring an additional 72,950 shares during the period. Annex Advisory Services LLC's holdings in Colgate-Palmolive were worth $6,991,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. State Street Corp increased its stake in Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares during the period. Geode Capital Management LLC increased its stake in Colgate-Palmolive by 2.8% in the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock valued at $2,095,325,000 after purchasing an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA increased its stake in Colgate-Palmolive by 6.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock valued at $988,997,000 after purchasing an additional 557,492 shares during the period. Legal & General Group Plc increased its stake in Colgate-Palmolive by 0.8% in the second quarter. Legal & General Group Plc now owns 7,785,101 shares of the company's stock valued at $755,465,000 after purchasing an additional 61,413 shares during the period. Finally, Barclays PLC increased its stake in Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.37% of the company's stock.

Colgate-Palmolive Trading Up 0.3 %

Shares of Colgate-Palmolive stock traded up $0.23 during trading hours on Monday, hitting $88.79. The company's stock had a trading volume of 5,149,874 shares, compared to its average volume of 3,679,883. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The business has a fifty day moving average of $92.20 and a 200 day moving average of $97.76. The company has a market capitalization of $72.55 billion, a PE ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's payout ratio is currently 57.31%.

Analyst Ratings Changes

CL has been the topic of a number of recent research reports. Barclays dropped their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a research note on Friday. UBS Group dropped their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a "buy" rating on the stock in a research note on Thursday. JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating on the stock in a research note on Thursday. TD Cowen dropped their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research note on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.